Elsevier

Neuroscience Letters

Volume 363, Issue 3, 17 June 2004, Pages 272-275
Neuroscience Letters

Nitroglycerin induces migraine headache and central sensitization phenomena in patients with migraine without aura: a study of laser evoked potentials

https://doi.org/10.1016/j.neulet.2004.04.029Get rights and content

Abstract

In migraineurs nitroglycerin (NTG) induces severe delayed headache, resembling spontaneous migraine attacks. The aim of the present study was to evaluate NTG laser evoked potentials (LEP) features amplitude and pain sensation to laser stimuli during NTG-induced headache. Nine patients were selected. Headache was induced by oral administration of 0.6 mg of NTG; signals were recorded through disk electrodes placed at the vertex and referred to linked earlobes. CO2-LEPs delivered by stimulation of the dorsum of both hands and the right and left supraorbital zones were evaluated after the onset of moderate or severe headache resembling spontaneous migraine and at least 72 h after the end of the headache phase. Patients exhibited a significant heat pain threshold reduction and an LEPs amplitude increment during headache when both the supraorbital zones were stimulated. NTG appeared to support a reliable experimental model of migraine, based on the neuronal effects on the integrative-nociceptive structures. The LEPs facilitation during NTG-induced headache may be subtended by a hyperactivity of nociceptive cortex as well as by a failure of pain-inhibitory control.

Cited by (42)

  • The effects of neonatal maternal deprivation and chronic unpredictable stresses on migraine-like behaviors in adult rats

    2022, Neuroscience Letters
    Citation Excerpt :

    In patients who suffer from migraine without aura, orally administered NTG exhibited a significant heat pain threshold reduction. The patients experienced a slight headache immediately after NTG intake and a moderate or severe subsequent headache accompanied by non-headache symptoms like nausea, vomiting, and photophobia [11]. In line with previous studies, our data shows that female rats manifest more severe NTG-induced migraine symptoms.

  • Gut microbiota and migraine

    2022, Neurobiology of Pain
    Citation Excerpt :

    Nitroglycerin (NTG) treatment in rodents has been used to model migraine after it was found clinically that a large percentage of patients being treated with nitrile drugs experience headache. The NTG model shares important features with what is seen in human migraine patients such as shared pain behaviors, central sensitization, and cortical spreading depression (de Tommaso et al. 2004; Knapp et al. 2017; Long et al. 2020). Rodent models employing single and chronic administration of NTG show both facial and hindpaw hypersensitivities as well as photophobia (Anapindi et al. 2019; Bates et al. 2010; Casili et al. 2020; Farajdokht et al. 2017; Farkas et al. 2016; Guo et al. 2021; Moye et al. 2019; Pan et al. 2022; Shu et al. 2020; Tang et al. 2018; Zhang et al. 2020a).

  • Nitric oxide role in anxiety-like behavior, memory and cognitive impairments in animal model of chronic migraine

    2020, Heliyon
    Citation Excerpt :

    NO is an important neurotransmitter in pain pathways and it is considered to play a fundamental role in migraine pathophysiology [7]. It has been demonstrated that the administration of nitroglycerin (NTG) as a nitric oxide donor induces a headache in healthy subjects and more severe delayed headache in migraineurs [8]. A lower cognitive performance has been reported in painful conditions [9].

  • Activation orexin 1 receptors in the ventrolateral periaqueductal gray matter attenuate nitroglycerin-induced migraine attacks and calcitonin gene related peptide up-regulation in trigeminal nucleus caudalis of rats

    2020, Neuropharmacology
    Citation Excerpt :

    The above pathway may promote the release of pro-nociceptive and pro-inflammatory mediators in both spinal and trigeminal nerves leading to peripheral and central sensitization. Consequently, an enhanced sensitivity for pain can be seen in migraine sufferers (de Tommaso et al., 2002, 2004). Orexin-A (OrxA) is produced by a small number of neurons in the lateral and posterior hypothalamic regions.

View all citing articles on Scopus
View full text